Position in NVS
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$4,624,493
+$335,427 QoQ
Shares Held
29,508
+5.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#272
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ballentine Partners, LLC holds $83,408,432 across 14 Drug Manufacturers - General names. NVS ranks #5 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
20,150 | $24,168,514 | |
| 2 | JNJ |
Johnson & Johnson
|
66,025 | $16,768,367 | |
| 3 | ABBV |
AbbVie Inc.
|
42,284 | $10,640,343 | |
| 4 | MRK |
Merck & Co., Inc.
|
52,463 | $6,741,493 | |
| 5 | NVS |
Novartis AG
This page
|
29,508 | $4,624,493 | |
| 6 | AZN |
Astrazeneca PLC
|
20,071 | $3,805,862 | |
| 7 | AMGN |
Amgen Inc
|
10,242 | $3,708,831 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
24,093 | $3,043,907 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,624,493 | 29,508 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $4,289,066 | 28,079 | Shares | Other | 2026-05-14 | |
| 2025-12-31 | $3,719,868 | 26,981 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $3,349,499 | 26,119 | Shares | Other | 2025-11-03 | |
| 2025-06-30 | $3,237,137 | 26,751 | Shares | Other | 2025-07-15 | |
| 2025-03-31 | $2,856,674 | 25,625 | Shares | Other | 2025-05-01 | |
| 2024-12-31 | $1,871,659 | 19,234 | Shares | Other | 2025-01-16 | |
| 2024-09-30 | $2,117,517 | 18,410 | Shares | Other | 2024-10-23 | |
| 2024-06-30 | $1,850,273 | 17,380 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $1,487,706 | 15,380 | Shares | Other | 2024-04-11 | |
| 2023-12-31 | $1,372,382 | 13,592 | Shares | Other | 2024-01-23 | |
| 2023-09-30 | $1,146,229 | 11,253 | Shares | Other | 2023-10-19 | |
| 2023-06-30 | $1,056,526 | 10,470 | Shares | Other | 2023-07-26 | |
| 2023-03-31 | $742,164 | 8,067 | Shares | Other | 2023-04-27 | |
| 2022-12-31 | $717,322 | 7,907 | Shares | Other | 2023-01-27 | |
| 2022-09-30 | $736,688 | 9,692 | Shares | Sole | 2022-10-26 | |
| 2022-06-30 | $816,052 | 9,654 | Shares | Other | 2022-08-09 | |
| 2022-03-31 | $1,079,763 | 12,305 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $756,090 | 8,644 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $705,270 | 8,624 | Shares | Other | 2021-10-27 | |
| 2021-06-30 | $739,590 | 8,106 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $693,755 | 8,116 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $812,662 | 8,606 | Shares | Other | 2021-01-25 | |
| 2020-09-30 | $731,507 | 8,412 | Shares | Other | 2020-10-22 | |
| 2020-06-30 | $700,815 | 8,024 | Shares | Other | 2020-07-31 | |
| 2020-03-31 | $685,735 | 8,317 | Shares | Other | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||